These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 30900977)

  • 1. Sequential Emergence and Wide Spread of Neutralization Escape Middle East Respiratory Syndrome Coronavirus Mutants, South Korea, 2015.
    Kim YS; Aigerim A; Park U; Kim Y; Rhee JY; Choi JP; Park WB; Park SW; Kim Y; Lim DG; Inn KS; Hwang ES; Choi MS; Shin HS; Cho NH
    Emerg Infect Dis; 2019 Jun; 25(6):1161-1168. PubMed ID: 30900977
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Spread of Mutant Middle East Respiratory Syndrome Coronavirus with Reduced Affinity to Human CD26 during the South Korean Outbreak.
    Kim Y; Cheon S; Min CK; Sohn KM; Kang YJ; Cha YJ; Kang JI; Han SK; Ha NY; Kim G; Aigerim A; Shin HM; Choi MS; Kim S; Cho HS; Kim YS; Cho NH
    mBio; 2016 Mar; 7(2):e00019. PubMed ID: 26933050
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mutations in the Spike Protein of Middle East Respiratory Syndrome Coronavirus Transmitted in Korea Increase Resistance to Antibody-Mediated Neutralization.
    Kleine-Weber H; Elzayat MT; Wang L; Graham BS; Müller MA; Drosten C; Pöhlmann S; Hoffmann M
    J Virol; 2019 Jan; 93(2):. PubMed ID: 30404801
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MERS-CoV Antibody Responses 1 Year after Symptom Onset, South Korea, 2015.
    Choe PG; Perera RAPM; Park WB; Song KH; Bang JH; Kim ES; Kim HB; Ko LWR; Park SW; Kim NJ; Lau EHY; Poon LLM; Peiris M; Oh MD
    Emerg Infect Dis; 2017 Jul; 23(7):1079-1084. PubMed ID: 28585916
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Recombinant Receptor-Binding Domains of Multiple Middle East Respiratory Syndrome Coronaviruses (MERS-CoVs) Induce Cross-Neutralizing Antibodies against Divergent Human and Camel MERS-CoVs and Antibody Escape Mutants.
    Tai W; Wang Y; Fett CA; Zhao G; Li F; Perlman S; Jiang S; Zhou Y; Du L
    J Virol; 2017 Jan; 91(1):. PubMed ID: 27795425
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genetic Characterization of Middle East Respiratory Syndrome Coronavirus, South Korea, 2018.
    Chung YS; Kim JM; Man Kim H; Park KR; Lee A; Lee NJ; Kim MS; Kim JS; Kim CK; Lee JI; Kang C
    Emerg Infect Dis; 2019 May; 25(5):958-962. PubMed ID: 30753126
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Variations in Spike Glycoprotein Gene of MERS-CoV, South Korea, 2015.
    Kim DW; Kim YJ; Park SH; Yun MR; Yang JS; Kang HJ; Han YW; Lee HS; Kim HM; Kim H; Kim AR; Heo DR; Kim SJ; Jeon JH; Park D; Kim JA; Cheong HM; Nam JG; Kim K; Kim SS
    Emerg Infect Dis; 2016 Jan; 22(1):100-4. PubMed ID: 26691200
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Analysis of intrapatient heterogeneity uncovers the microevolution of Middle East respiratory syndrome coronavirus.
    Park D; Huh HJ; Kim YJ; Son DS; Jeon HJ; Im EH; Kim JW; Lee NY; Kang ES; Kang CI; Chung DR; Ahn JH; Peck KR; Choi SS; Kim YJ; Ki CS; Park WY
    Cold Spring Harb Mol Case Stud; 2016 Nov; 2(6):a001214. PubMed ID: 27900364
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characterization of novel monoclonal antibodies against MERS-coronavirus spike protein.
    Goo J; Jeong Y; Park YS; Yang E; Jung DI; Rho S; Park U; Sung H; Park PG; Choi JA; Seo SH; Cho NH; Lee H; Lee JM; Kim JO; Song M
    Virus Res; 2020 Mar; 278():197863. PubMed ID: 31945421
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Middle East respiratory syndrome coronavirus Spike protein variants exhibit geographic differences in virulence.
    Wong LR; Zheng J; Sariol A; Lowery S; Meyerholz DK; Gallagher T; Perlman S
    Proc Natl Acad Sci U S A; 2021 Jun; 118(24):. PubMed ID: 34099556
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cross-Protection against MERS-CoV by Prime-Boost Vaccination Using Viral Spike DNA and Protein.
    Choi JA; Goo J; Yang E; Jung DI; Lee S; Rho S; Jeong Y; Park YS; Park H; Moon YH; Park U; Seo SH; Lee H; Lee JM; Cho NH; Song M; Kim JO
    J Virol; 2020 Nov; 94(24):. PubMed ID: 32967955
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A Novel Nanobody Targeting Middle East Respiratory Syndrome Coronavirus (MERS-CoV) Receptor-Binding Domain Has Potent Cross-Neutralizing Activity and Protective Efficacy against MERS-CoV.
    Zhao G; He L; Sun S; Qiu H; Tai W; Chen J; Li J; Chen Y; Guo Y; Wang Y; Shang J; Ji K; Fan R; Du E; Jiang S; Li F; Du L; Zhou Y
    J Virol; 2018 Sep; 92(18):. PubMed ID: 29950421
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Microevolution of Outbreak-Associated Middle East Respiratory Syndrome Coronavirus, South Korea, 2015.
    Seong MW; Kim SY; Corman VM; Kim TS; Cho SI; Kim MJ; Lee SJ; Lee JS; Seo SH; Ahn JS; Yu BS; Park N; Oh MD; Park WB; Lee JY; Kim G; Joh JS; Jeong I; Kim EC; Drosten C; Park SS
    Emerg Infect Dis; 2016 Feb; 22(2):327-30. PubMed ID: 26814649
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ultrapotent Human Neutralizing Antibody Repertoires Against Middle East Respiratory Syndrome Coronavirus From a Recovered Patient.
    Niu P; Zhang S; Zhou P; Huang B; Deng Y; Qin K; Wang P; Wang W; Wang X; Zhou J; Zhang L; Tan W
    J Infect Dis; 2018 Sep; 218(8):1249-1260. PubMed ID: 29846635
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Towards a solution to MERS: protective human monoclonal antibodies targeting different domains and functions of the MERS-coronavirus spike glycoprotein.
    Widjaja I; Wang C; van Haperen R; Gutiérrez-Álvarez J; van Dieren B; Okba NMA; Raj VS; Li W; Fernandez-Delgado R; Grosveld F; van Kuppeveld FJM; Haagmans BL; Enjuanes L; Drabek D; Bosch BJ
    Emerg Microbes Infect; 2019; 8(1):516-530. PubMed ID: 30938227
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of human neutralizing antibodies against MERS-CoV and their role in virus adaptive evolution.
    Tang XC; Agnihothram SS; Jiao Y; Stanhope J; Graham RL; Peterson EC; Avnir Y; Tallarico AS; Sheehan J; Zhu Q; Baric RS; Marasco WA
    Proc Natl Acad Sci U S A; 2014 May; 111(19):E2018-26. PubMed ID: 24778221
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Blocking transmission of Middle East respiratory syndrome coronavirus (MERS-CoV) in llamas by vaccination with a recombinant spike protein.
    Rodon J; Okba NMA; Te N; van Dieren B; Bosch BJ; Bensaid A; Segalés J; Haagmans BL; Vergara-Alert J
    Emerg Microbes Infect; 2019; 8(1):1593-1603. PubMed ID: 31711379
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Superior immune responses induced by intranasal immunization with recombinant adenovirus-based vaccine expressing full-length Spike protein of Middle East respiratory syndrome coronavirus.
    Kim MH; Kim HJ; Chang J
    PLoS One; 2019; 14(7):e0220196. PubMed ID: 31329652
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of Fc Fusion on Folding and Immunogenicity of Middle East Respiratory Syndrome Coronavirus Spike Protein.
    Chun J; Cho Y; Park KH; Choi H; Cho H; Lee HJ; Jang H; Kim KH; Oh YK; Kim YB
    J Microbiol Biotechnol; 2019 May; 29(5):813-819. PubMed ID: 30982320
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Heterologous prime-boost vaccination with adenoviral vector and protein nanoparticles induces both Th1 and Th2 responses against Middle East respiratory syndrome coronavirus.
    Jung SY; Kang KW; Lee EY; Seo DW; Kim HL; Kim H; Kwon T; Park HL; Kim H; Lee SM; Nam JH
    Vaccine; 2018 Jun; 36(24):3468-3476. PubMed ID: 29739720
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.